Manila : Testosterone enanthate for HRT ftm : Other Health & Beauty For Sale

Welcome, Guest ( Register | Login )
<< Previous Next >>

Testosterone enanthate for HRT ftm  - ₱1,000.00 PHp Listing ID: 1547108

Seller Info


Member Since:
Mar 5-13:33

, Manila, Metro Manila, Philippines


Seller Notes

Seller Accepts:

Sponsored Links

Classified Info

Listing Began: 3/19/18
Number of Times Viewed: 26

Image 1 of 1


Seller's Comments and Description:

For sale testosterone enanthate 10ml
You can use it for 4weeks
Dosage per week 100mg-200mg

Testosterone enanthate 10ml - 1000

Txt me at 09273713290 for orders.
Minimum order (3)
Discount for bulk orders.

The most well-described formulation of testosterone therapy used to treat FtM patients is intramuscular injection of testosterone esters (cypionate or enanthate). These injections are given every 1–2 weeks based on patient response and adverse effects. Dosing may be administered at 1-week intervals if patients sense peaks and troughs in their testosterone levels, translating to cyclic variations in mood or virilism. Injection site reactions can be common with intramuscular testosterone, with up to 33% of hypogonadal men who received the injections having local reactions. Because of the viscous nature of the injectable formulation and the need to inject into muscle to obtain an extended duration, a 1.5-inch, 22-gauge needle is often used. This can be a deterrent to some people despite the infrequent dosing. In addition, if the patient is unable to self-administer, although injectable testosterone is less expensive than transdermal, the cost of office visit charges to administer the drug can be a financial burden to the patient.

Other supplemental agents have been used with testosterone if menses does not cease. In fact, supplemental therapy is very frequently needed to stop menses. Depot medroxyprogesterone has shown efficacy in stopping menses and reducing estrogen levels to concentrations found biologically in men. Intramuscular medroxyprogesterone 150 mg every 3 months can be given when starting testosterone and is usually discontinued after the patient has had 3–6 months of testosterone therapy. Exposure of medroxyprogesterone should be limited in an attempt to reduce the risk of endometrial hyperplasia.

Effectiveness of Therapy

Evaluation of FtM patients using testosterone therapy has provided an accepted timeline of when physical sex characteristics of men should present.

The testosterone preparations vary in their effectiveness, with injectable formulations typically associated with the most substantial increases in testosterone levels and more rapid physical changes in the FtM patient. Although no substantial, published data currently demonstrate the effectiveness of injectable formulations compared with other formulations, patient and provider reports consistently demonstrate this trend.

Monitoring and Safety

Commonly described effects noted in FtM patients using testosterone include development or worsening of acne, increased musculature, increased hair growth, enlargement of the clitoris, vaginal tissue atrophy, and possible psychiatric changes.